Dr. Kevan Shokat is currently an investigator of the Howard Hughes Medical Institute, vice-chair of and professor in the Department of Cellular and Molecular Pharmacology at the University of California San Francisco (UCSF) and professor in the Department of Chemistry at the University of California Berkeley. He received his BA in chemistry from Reed College in 1986. After receiving his PhD in organic chemistry at UC Berkeley with Professor Peter Schultz, and postdoctoral work in immunology at Stanford University with Professor Chris Goodnow, he began his independent research career at Princeton University before moving to UCSF in 1999. He has been inducted into the National Academy of Sciences (2010), the Institute of Medicine (2011) and the American Academy of Arts and Sciences (2011). He has commercialized discoveries from his laboratory through co-founding several biotechnology companies including, Cellular Genomics, Intellikine, Araxes, Kura, eFFECTOR, Revolution Medicines and Mitokinin.